Position in A
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$353,726
+$46,778 QoQ
Shares Held
2,663
-1.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#701
of 1,112 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in A Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026FIDELIS CAPITAL PARTNERS, LLC holds $5,170,375 across 5 Diagnostics & Research names. A ranks #5 (6.8% of the industry book) .
All Filings in A
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $353,726 | 2,663 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $306,948 | 2,693 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $377,594 | 2,775 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $360,278 | 2,807 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $324,173 | 2,747 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $349,536 | 2,988 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $389,586 | 2,900 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $422,425 | 2,845 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $234,371 | 1,808 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $417,904 | 2,872 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $375,937 | 2,704 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $233,256 | 2,086 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $241,943 | 2,012 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $261,877 | 1,893 | Shares | Sole | 2023-05-09 | |
| No filing history on record for this holder in this stock. | ||||||